- Portfolio Prep for Next Week: 'Don't Get Crazy'
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Surprising Options Trades in TiVo Shares
- 10 Dividend Picks For Your Portfolio: Chief Investors
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Retail Earnings and Sales to Improve in Q4: Analyst
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
MOST SHARED
- Tiger Woods Out of Hospital After Accident
- The Good Entrepreneur Winner
- Get Paid Six Figures to Wear a T-Shirt?
- Global Selloff From Dubai Woes Shows Signs of Winding Down
- Halftime Report: Dubai - First Ripple Of Larger Crisis?
- Longer Lines, Fuller Carts This Black Friday
- Dubai Spooks Investors But May Bring Buying Opportunity
- Next Week: Cash In Now Or Wait For A Santa Rally?
- Commodities Hammered as Investors Flee to US Dollars
- U.S. Stocks Fall on Dubai Worries
- Black Friday at Best Buy
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Longer Lines, Fuller Carts This Black Friday
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Obama's Emission Reduction Pledge Paints Future for Autos
- Is Super Bowl Halftime Act Too Old?
- Surprising Options Trades in TiVo Shares
- EA Sports Hopes to Pump Up Sales Through Pop-Up Locations
- Global Selloff From Dubai Shows Signs of Winding Down
- Dubai Stock Selloff May Bring Buying Opportunity
- Longer Lines, Fuller Carts This Black Friday
- Tiger Woods Out of Hospital After Accident
- Dubai Fallout Is a Correction, Not Another Crisis: El-Erian
- Dubai's Debt Woes Signal New Era for Creditors
- Get Paid Six Figures to Wear a T-Shirt?
- The World's Biggest Debtor Nations
- Five Tips for Buying a Foreclosed Home
RSS FEED
CNBC Stock Blog
Text Size 
Investors can benefit from certain health care companies that will be boosted by the stimulus package, said Les Funtleyder, health care strategist of Miller Tabak.
“We’re just looking at fundamentals rather than macro,” he told CNBC. “We’re looking specifically at the genetic analysis space like the Illuminas and Luminexes of the world.”
Funtleyder Likes:
Illumina [ILMN
Loading...
()
]
UnitedHealth [UNH
Loading...
()
]
“We also like the vaccine and diagnostic companies,” said Funtleyder.
Vaccine-Maker Picks:
Novartis [NVS
Loading...
()
]
Sanofi-Aventis [SNY
Loading...
()
]
GlaxoSmithKline [GSK
Loading...
()
]
Luminex [LMNX
Loading...
()
]
However, he said investors who are worried about risk should avoid the long-term care facilities.
Disclosure:
Funtleyer does not own shares of any of the companies mentioned above.
Data is a real-time snapshot *Data is delayed at least 15 minutes